Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Clinical trial NCT06016634 · RECRUITING

Trial details

NCT number: NCT06016634
Sponsor: University of California, Davis
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Anemia Osteonecrosis Ischemic Necrosis Avascular Necrosis

Start date: 2026-03-09
Primary completion: 2027-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.